ProShares UltraShort NASDAQ Biotechnology
15 hedge funds and large institutions have $17M invested in ProShares UltraShort NASDAQ Biotechnology in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
15
Holding in Top 10
–
Calls
$8.94M
Puts
$4.65M
Top Buyers
| 1 | +$643K | |
| 2 | +$213K | |
| 3 | +$55.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.13K |
Top Sellers
| 1 | -$7.13M | |
| 2 | -$5.61M | |
| 3 | -$2.58M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.78M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.51M |